Literature DB >> 28878301

EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase- and COX-derived oxidative stress.

Zahid Rasul Niazi1, Grazielle C Silva1, Thais Porto Ribeiro1, Antonio J León-González1, Mohamad Kassem2, Abdur Mirajkar3, Azhar Alvi3, Malak Abbas1, Faraj Zgheel1,4, Valérie B Schini-Kerth1, Cyril Auger1.   

Abstract

Eicosapentaenoic acid:docosahexaenoic acid (EPA:DHA) 6:1, an omega-3 polyunsaturated fatty acid formulation, has been shown to induce a sustained formation of endothelial nitric oxide (NO) synthase-derived NO, a major vasoprotective factor. This study examined whether chronic intake of EPA:DHA 6:1 prevents hypertension and endothelial dysfunction induced by angiotensin II (Ang II) in rats. Male Wister rats received orally corn oil or EPA:DHA 6:1 (500 mg kg-1 per day) before chronic infusion of Ang II (0.4 mg kg-1 per day). Systolic blood pressure was determined by tail cuff sphingomanometry, vascular reactivity using a myograph, oxidative stress using dihydroethidium and protein expression by immunofluorescence and western blot analysis. Ang II-induced hypertension was associated with reduced acetylcholine-induced relaxations of secondary branch mesenteric artery rings affecting the endothelium-dependent hyperpolarization (EDH)- and the NO-mediated relaxations, both of which were improved by the NADPH oxidase inhibitor VAS-2870. The Ang II treatment induced also endothelium-dependent contractile responses (EDCFs), which were abolished by the cyclooxygenase (COX) inhibitor indomethacin. An increased level of vascular oxidative stress and expression of NADPH oxidase subunits (p47phox and p22phox), COX-1 and COX-2, endothelial NO synthase and Ang II type 1 receptors were observed in the Ang II group, whereas SKCa and connexin 37 were downregulated. Intake of EPA:DHA 6:1 prevented the Ang II-induced hypertension and endothelial dysfunction by improving both the NO- and EDH-mediated relaxations, and by reducing EDCFs and the expression of target proteins. The present findings indicate that chronic intake of EPA:DHA 6:1 prevented the Ang II-induced hypertension and endothelial dysfunction in rats, most likely by preventing NADPH oxidase- and COX-derived oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28878301     DOI: 10.1038/hr.2017.72

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  61 in total

1.  Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients.

Authors:  Richard J Woodman; Trevor A Mori; Valerie Burke; Ian B Puddey; Anne Barden; Gerald F Watts; Lawrence J Beilin
Journal:  Atherosclerosis       Date:  2003-01       Impact factor: 5.162

2.  Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats.

Authors:  Sae Mi Yoo; Sung Hyun Choi; Monica Dha Yea Jung; Sung Cil Lim; Sang Hong Baek
Journal:  Hypertens Res       Date:  2014-10-16       Impact factor: 3.872

3.  Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.

Authors:  Arzu Ulu; Todd R Harris; Christophe Morisseau; Christina Miyabe; Hiromi Inoue; Gertrud Schuster; Hua Dong; Ana-Maria Iosif; Jun-Yan Liu; Robert H Weiss; Nipavan Chiamvimonvat; John D Imig; Bruce D Hammock
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

Review 4.  The importance of the ratio of omega-6/omega-3 essential fatty acids.

Authors:  A P Simopoulos
Journal:  Biomed Pharmacother       Date:  2002-10       Impact factor: 6.529

Review 5.  Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.

Authors:  Hiroyuki Seki; Yukako Tani; Makoto Arita
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-25       Impact factor: 3.072

Review 6.  Endothelial dysfunction and vascular disease - a 30th anniversary update.

Authors:  P M Vanhoutte; H Shimokawa; M Feletou; E H C Tang
Journal:  Acta Physiol (Oxf)       Date:  2016-01-25       Impact factor: 6.311

7.  The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension.

Authors:  H R Knapp; G A FitzGerald
Journal:  N Engl J Med       Date:  1989-04-20       Impact factor: 91.245

8.  Aliskiren and l-arginine treatments restore depressed baroreflex sensitivity and decrease oxidative stress in renovascular hypertension rats.

Authors:  Vinicius Mengal; Paulo Hm Silva; Renata V Tiradentes; Cintia H Santuzzi; Simone A de Almeida; Gabriela C Sena; Nazare S Bissoli; Glaucia R Abreu; Sonia A Gouvea
Journal:  Hypertens Res       Date:  2016-07-07       Impact factor: 3.872

9.  Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system.

Authors:  Noureddine Idris Khodja; Thierry Chataigneau; Cyril Auger; Valérie B Schini-Kerth
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

Review 10.  Omega-3 fatty acids and inflammatory processes.

Authors:  Philip C Calder
Journal:  Nutrients       Date:  2010-03-18       Impact factor: 6.706

View more
  9 in total

Review 1.  NADPH oxidase family proteins: signaling dynamics to disease management.

Authors:  Rizwana Begum; Shilpa Thota; Abubakar Abdulkadir; Gagandeep Kaur; Prathyusha Bagam; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2022-05-18       Impact factor: 22.096

2.  Blood Pressure-Lowering Effects of Omega-3 Polyunsaturated Fatty Acids: Are These the Missing Link to Explain the Relationship Between Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Disease?

Authors:  Marc George; Ajay Gupta
Journal:  J Am Heart Assoc       Date:  2022-06-01       Impact factor: 6.106

3.  Effects of Docosahexaenoic Acid and Its Peroxidation Product on Amyloid-β Peptide-Stimulated Microglia.

Authors:  Xue Geng; Bo Yang; Runting Li; Tao Teng; Mary Jo Ladu; Grace Y Sun; C Michael Greenlief; James C Lee
Journal:  Mol Neurobiol       Date:  2019-11-01       Impact factor: 5.590

4.  Significance of neutrophil microparticles in ischaemia-reperfusion: Pro-inflammatory effectors of endothelial senescence and vascular dysfunction.

Authors:  Ali El Habhab; Raed Altamimy; Malak Abbas; Mohamad Kassem; Lamia Amoura; Abdul Wahid Qureshi; Hanine El Itawi; Guillaume Kreutter; Sonia Khemais-Benkhiat; Fatiha Zobairi; Valérie B Schini-Kerth; Laurence Kessler; Florence Toti
Journal:  J Cell Mol Med       Date:  2020-06-10       Impact factor: 5.310

5.  Omega-3 fatty acids ameliorate doxorubicin-induced cardiorenal toxicity: In-vivo regulation of oxidative stress, apoptosis and renal Nox4, and in-vitro preservation of the cytotoxic efficacy.

Authors:  Dalia Saleh; Marawan Abdelbaset; Azza Hassan; Ola Sharaf; Sawsan Mahmoud; Rehab Hegazy
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

6.  Diverse associations between oxidative stress and thromboxane A2 in hypertensive glomerular injury.

Authors:  Yukihito Nakano; Yoshihisa Nakatani; Masahiro Takami; Yoshihiro Taniyama; Shuji Arima
Journal:  Hypertens Res       Date:  2018-12-13       Impact factor: 3.872

Review 7.  The Effects of Fish Oil on Cardiovascular Diseases: Systematical Evaluation and Recent Advance.

Authors:  Jia Liao; Qingsong Xiong; Yuehui Yin; Zhiyu Ling; Shaojie Chen
Journal:  Front Cardiovasc Med       Date:  2022-01-05

8.  Oral Intake of EPA:DHA 6:1 by Middle-Aged Rats for One Week Improves Age-Related Endothelial Dysfunction in Both the Femoral Artery and Vein: Role of Cyclooxygenases.

Authors:  Sébastien Gaertner; Cyril Auger; Muhammad A Farooq; Brigitte Pollet; Sonia Khemais-Benkhiat; Zahid R Niazi; Sophie Schrevens; Sin-Hee Park; Florence Toti; Dominique Stephan; Valérie B Schini-Kerth
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

9.  Homocysteine Causes Endothelial Dysfunction via Inflammatory Factor-Mediated Activation of Epithelial Sodium Channel (ENaC).

Authors:  Chen Liang; Qiu-Shi Wang; Xu Yang; Di Zhu; Yu Sun; Na Niu; Jie Yao; Bi-Han Dong; Shuai Jiang; Liang-Liang Tang; Jie Lou; Chang-Jiang Yu; Qun Shao; Ming-Ming Wu; Zhi-Ren Zhang
Journal:  Front Cell Dev Biol       Date:  2021-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.